These findings possibly suggest that NGR1 pretreatment promotes hiPSC-CM survival post-transplantation and improves the therapeutic efficacy of hiPSC-CM transplantation in MI via PI3K/Akt pathway activation. This evidence concerns the gene AKT1 and myocardial infarction.